|
CTPS2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.614800E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.436000E-03 |
| Normal-vs-Stage2 |
1.899650E-02 |
| Normal-vs-Stage3 |
1.62028999999286E-05 |
| Normal-vs-Stage4 |
1.260990E-03 |
| Stage1-vs-Stage2 |
7.495600E-01 |
| Stage1-vs-Stage3 |
1.370380E-02 |
| Stage1-vs-Stage4 |
1.420570E-01 |
| Stage2-vs-Stage3 |
1.461780E-01 |
| Stage2-vs-Stage4 |
4.262200E-01 |
| Stage3-vs-Stage4 |
5.937800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.97479999999906E-05 |
| Normal-vs-AfricanAmerican |
2.556300E-02 |
| Normal-vs-Asian |
1.467780E-01 |
| Caucasian-vs-AfricanAmerican |
5.971600E-01 |
| Caucasian-vs-Asian |
3.930200E-02 |
| AfricanAmerican-vs-Asian |
4.179100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.78713999999802E-05 |
| Normal-vs-Female |
3.949600E-02 |
| Male-vs-Female |
2.164200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.451450E-01 |
| Normal-vs-Age(41-60Yrs) |
1.102610E-03 |
| Normal-vs-Age(61-80Yrs) |
7.241900E-04 |
| Normal-vs-Age(81-100Yrs) |
1.800960E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.511200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.968200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.439600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.553600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.169200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.490800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.144400E-01 |
| Normal-vs-Grade 2 |
1.689670E-02 |
| Normal-vs-Grade 3 |
8.48810000000366E-05 |
| Normal-vs-Grade 4 |
1.91815999999179E-05 |
| Grade 1-vs-Grade 2 |
6.944100E-02 |
| Grade 1-vs-Grade 3 |
9.799200E-03 |
| Grade 1-vs-Grade 4 |
2.636600E-03 |
| Grade 2-vs-Grade 3 |
2.360100E-02 |
| Grade 2-vs-Grade 4 |
3.558000E-03 |
| Grade 3-vs-Grade 4 |
2.060000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.833900E-04 |
| Normal-vs-ccB subtype |
2.843800E-03 |
| ccA subtype-vs-ccB subtype |
7.642600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.209500E-04 |
| Normal-vs-N1 |
2.357500E-02 |
| N0-vs-N1 |
5.478200E-01 |
|
|
